Monday = Sanofi Executes Option to develop, manufacture and commercialise a respiratory disease self-assessment application specifically for consumers
Tuesday = FDA Classification for de novo Class II Medical device for respiratory disease diagnosis in paediatrics
Wednesday sp = 0.40
FMD...patience of a rock required
Monday = Sanofi Executes Option to develop, manufacture and...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)